ES2118254T3 - Sales de amonio polimericas reticuladas. - Google Patents

Sales de amonio polimericas reticuladas.

Info

Publication number
ES2118254T3
ES2118254T3 ES93920051T ES93920051T ES2118254T3 ES 2118254 T3 ES2118254 T3 ES 2118254T3 ES 93920051 T ES93920051 T ES 93920051T ES 93920051 T ES93920051 T ES 93920051T ES 2118254 T3 ES2118254 T3 ES 2118254T3
Authority
ES
Spain
Prior art keywords
atoms
approximately
ammonium
groups
ammonium salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93920051T
Other languages
English (en)
Inventor
Garret Daniel Figuly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Application granted granted Critical
Publication of ES2118254T3 publication Critical patent/ES2118254T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • C08G73/0226—Quaternisation of polyalkylene(poly)amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyethers (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Silicon Polymers (AREA)
  • Steroid Compounds (AREA)

Abstract

SE PRESENTAN SALES DE AMONIO POLIMERICO RETICULADAS DONDE EN DICHA SAL: APROXIMADAMENTE EL 25% O MAS DE LOS GRUPOS QUE ENLAZAN ATOMOS DE NITROGENO DE AMONIO SON DE GRUPOS Y, DONDE Y ES UN GRUPO N-ALQUILENO O GRUPO N-ALQUILENO SUSTITUIDO DE ALQUILO, DONDE DICHO GRUPO N-ALQUILENO TIENE 7 A APROXIMADAMENTE 20 ATOMOS DE CARBONO; EL CERO APROXIMADAMENTE EL 75% QUE ENLAZA ATOMOS DE NITROGENO DE AMONIO SON GRUPOS Z DONDE Z ES UN RADICAL HIDROCARBILENO QUE CONTIENE 2 O MAS ATOMOS DE CARBONO, CONTENIENDO OPCIONALMENTE DICHO RADICAL HIDROCARBILENO UNO O MAS GRUPOS HIDROXILO, ETER, AMINO TIOETER, CETO, O SILILO O ANILLOS HETEROCICLICOS; Y APROXIMADAMENTE EL 25% O MAS DE LOS ATOMOS DE AMONIO SON ATOMOS DE AMONIO SECUNDARIO.
ES93920051T 1992-08-20 1993-08-18 Sales de amonio polimericas reticuladas. Expired - Lifetime ES2118254T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93244992A 1992-08-20 1992-08-20

Publications (1)

Publication Number Publication Date
ES2118254T3 true ES2118254T3 (es) 1998-09-16

Family

ID=25462341

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93920051T Expired - Lifetime ES2118254T3 (es) 1992-08-20 1993-08-18 Sales de amonio polimericas reticuladas.

Country Status (23)

Country Link
US (2) US5633344A (es)
EP (1) EP0656029B1 (es)
JP (1) JPH08500386A (es)
KR (1) KR950703016A (es)
CN (1) CN1088223A (es)
AT (1) ATE168707T1 (es)
AU (1) AU672824B2 (es)
CA (1) CA2142826A1 (es)
CZ (1) CZ43995A3 (es)
DE (1) DE69319914T2 (es)
DK (1) DK0656029T3 (es)
ES (1) ES2118254T3 (es)
FI (1) FI950704L (es)
GR (1) GR3027584T3 (es)
HU (1) HUT72658A (es)
IL (1) IL106733A (es)
MX (1) MX9305077A (es)
NZ (1) NZ255758A (es)
PL (1) PL307527A1 (es)
RU (1) RU95107405A (es)
SK (1) SK31395A3 (es)
WO (1) WO1994004596A1 (es)
ZA (1) ZA936127B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556619A (en) * 1992-08-20 1996-09-17 The Du Pont Merck Pharmaceutical Company Crosslinked polymeric ammonium salts
US6129910A (en) * 1993-06-02 2000-10-10 Geltex Pharmaceuticals, Inc. Water-insoluble noncrosslinked bile acid sequestrants
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5900475A (en) * 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
MX9602812A (es) * 1994-01-18 1997-06-28 Du Pont Sales de amonio polimericas, reticuladas.
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
WO1996021454A1 (en) * 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6294163B1 (en) * 1998-10-02 2001-09-25 Geltex Pharmaceuticals, Inc. Polymers containing guanidinium groups as bile acid sequestrants
DK1129064T3 (da) 1998-11-12 2008-04-28 Invitrogen Corp Transfektionsreagenser
WO2000038664A2 (en) * 1998-12-23 2000-07-06 Geltex Pharmaceuticals, Inc. Amine condensation polymer bile acid sequestrants
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US6649187B2 (en) 2001-02-16 2003-11-18 Bristol-Myers Squibb Pharma Company Use of polyalkylamine polymers in controlled release devices
US20030096414A1 (en) 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
EP1732973A1 (en) * 2004-02-23 2006-12-20 E.I.Du pont de nemours and company Crosslinked polymers containing biomass derived materials
NO322564B1 (no) * 2004-03-22 2006-10-23 Ntnu Technology Transfer As Komposittmembran, fremgangsmate til fremstilling derav, samt anvendelse derav for separasjon av CO2 fra gassblandinger.
US7556799B2 (en) * 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US7854924B2 (en) * 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
BRPI0509331B8 (pt) * 2004-03-30 2021-05-25 Ilypsa Inc uso de uma composição de ligação de sódio
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
US7429394B2 (en) * 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP3000460A1 (en) 2005-09-15 2016-03-30 Genzyme Corporation Sachet formulation for amine polymers
GB2446077B (en) 2005-09-30 2010-10-13 Ilypsa Inc Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal
CA2624112A1 (en) * 2005-09-30 2007-04-05 Ilypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
US8337824B2 (en) 2008-08-22 2012-12-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
US20100104527A1 (en) * 2008-08-22 2010-04-29 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
MX389664B (es) * 2008-08-22 2025-03-20 Vifor Int Ltd Polimeros reticulados de intercambio cationico, composiciones y su uso en el tratamiento de la hipercalcemia
DE112011100657T5 (de) * 2010-02-24 2013-02-28 Relypsa, Inc. Amin-polymere zur verwendung als gallensäuresequestriermittel
US9550725B2 (en) * 2011-11-25 2017-01-24 Basf Se Lipophilic polyalkylenepolyamines by homogeneously catalyzed alcohol amination
JP6475624B2 (ja) 2012-10-08 2019-02-27 レリプサ， インコーポレイテッド 高血圧症及び高カリウム血症を治療するためのカリウム結合剤
CN103351444B (zh) * 2013-06-20 2015-04-15 山东诚创医药技术开发有限公司 包含n或氨基,铵或螺双环铵基团的交联聚合物凝胶的过滤洗涤方法
KR101631151B1 (ko) * 2014-05-22 2016-06-27 한국과학기술연구원 탄화수소계열 전해질 고분자 합성 방법 및 이에 사용되는 중합 용매
WO2016011203A1 (en) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
CN107709477B (zh) 2015-04-30 2021-10-29 科慕埃弗西有限公司 包含可交联聚合物添加剂的耐久性建筑涂料
WO2022061279A1 (en) 2020-09-21 2022-03-24 Stride Cross-linked polymeric ammonium salts and their use in absorbing organic contaminants
US12434222B2 (en) 2020-09-21 2025-10-07 Stride Cross-linked polymeric ammonium salts and their use in absorbing organic contaminants
CN113583256B (zh) * 2021-07-05 2022-10-25 南京理工大学 一种阳离子水凝胶材料的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE467746A (es) * 1945-09-15
US3383281A (en) * 1961-09-22 1968-05-14 Merck & Co Inc Method for binding bile acids in vivo
US3332841A (en) * 1961-10-04 1967-07-25 Lilly Co Eli Method of treating hyperacidity
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
US4027009A (en) * 1973-06-11 1977-05-31 Merck & Co., Inc. Compositions and methods for depressing blood serum cholesterol
US4205064A (en) * 1973-06-11 1980-05-27 Merck & Co., Inc. Bile acid sequestering composition containing poly[{alkyl-(3-ammoniopropyl)imino}-trimethylenedihalides]
US4147586A (en) * 1974-09-14 1979-04-03 Monsanto Company Cellulosic paper containing the reaction product of a dihaloalkane alkylene diamine adduct and epihalohydrin
US4071478A (en) * 1976-06-07 1978-01-31 Merck & Co., Inc. Controlled partially cross-linked 3,3-ionenes
JPS5566513A (en) * 1978-11-14 1980-05-20 Ono Pharmaceut Co Ltd Drug for arteriosclerosis comprising high polymer compound as active constituent
US4374244A (en) * 1979-04-13 1983-02-15 Kewanee Industries, Inc. Linear quaternary ammonium polymers
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
JPS60209523A (ja) * 1984-04-03 1985-10-22 Mitsubishi Petrochem Co Ltd コレステロ−ル低下剤
DE3609984A1 (de) * 1986-03-25 1987-10-01 Bayer Ag Verfahren zur behandlung von fasermaterialien
US5236701A (en) * 1989-07-19 1993-08-17 Lowchol Scientific Inc. Ingestible hydrophilic polymeric amines useful for lowering blood cholesterol
CA2042870C (en) * 1991-05-17 1996-11-26 Leon Edward St. Pierre Metal ion coordinated polyamine resins for the lowering of blood cholesterol

Also Published As

Publication number Publication date
FI950704A0 (fi) 1995-02-16
KR950703016A (ko) 1995-08-23
EP0656029B1 (en) 1998-07-22
GR3027584T3 (en) 1998-11-30
CN1088223A (zh) 1994-06-22
US5633344A (en) 1997-05-27
IL106733A0 (en) 1993-12-08
PL307527A1 (en) 1995-05-29
WO1994004596A1 (en) 1994-03-03
DE69319914D1 (de) 1998-08-27
FI950704A7 (fi) 1995-02-16
ZA936127B (en) 1995-02-20
AU672824B2 (en) 1996-10-17
HUT72658A (en) 1996-05-28
SK31395A3 (en) 1995-08-09
FI950704L (fi) 1995-02-16
CZ43995A3 (en) 1995-12-13
NZ255758A (en) 1997-10-24
HU9500475D0 (en) 1995-04-28
US5667774A (en) 1997-09-16
JPH08500386A (ja) 1996-01-16
RU95107405A (ru) 1997-02-10
AU5010993A (en) 1994-03-15
MX9305077A (es) 1994-06-30
ATE168707T1 (de) 1998-08-15
DE69319914T2 (de) 1999-01-21
IL106733A (en) 1998-06-15
DK0656029T3 (da) 1999-02-15
EP0656029A1 (en) 1995-06-07
CA2142826A1 (en) 1994-03-03

Similar Documents

Publication Publication Date Title
ES2118254T3 (es) Sales de amonio polimericas reticuladas.
ES2072779T3 (es) Derivados aminoacidos anfoteros.
ES2160696T3 (es) Sales de amonio polimeras reticuladas.
ES2036551T3 (es) Compuestos heterociclicos.
AR246275A1 (es) Composiciones de catalizador, procedimiento para la preparacion de polimeros de monoxido de carbono, y eteno y nuevo compuesto.
UA5928A1 (uk) Спосіб отримання похідних дистаміцину а або їх гідрохлоридів
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
ES8607970A1 (es) Un procedimiento para la obtencion de derivados de hexahidro-3-oxo-piridinas.
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
ES2065924T3 (es) Estabilizadores a base de amidas bloqueadas n-substituidas.
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
SE7514049L (sv) Sett att generera en ph-funktion for anvendning vid separation
MX165512B (es) Aditivo de carbamato para composicion lubricante
BG29135A3 (en) Method of obtaining of acyclic and alycyclic n- substituated halo- 2- pyrolidinon
FR2398718A1 (fr) Nouvelles amines primaires utiles a la preparation de derives d'aminoalkyl benzenes
BR8907156A (pt) Composicao liquida e processo para obter uma composicao liquida
ES479668A1 (es) Un procedimiento para la preparacion de nuevas 5-alquil- ciopirimidinas.
MX9301045A (es) Procedimiento para preparar antagonistas receptores de fibrinogeno.
ES2057216T3 (es) N-(1,4-benzodiazepin-3-il) amidas de acidos 1h-indol-2-carboxilicos condensados en posiciones 1,7.
ES8707269A1 (es) Procedimiento para producir un objeto de composicion curada de bismaleimida o isomero de isomaleimida
ES2083387T3 (es) Peptidos sinteticos y sus mezclas para la deteccion de anticuerpos hiv.
ES2058383T3 (es) Derivados de acidos carboxilicos azaciclicos, su preparacion y uso.
ES539867A0 (es) Procedimiento para producir microsoportes de cultivos de ce-lulas
BG32418A3 (en) Method for obtaining of amid derivatives of 1, 2, 3- thiadiazol- 5- carbonic acid
ES2059595T3 (es) Beta-carbonil-carboxiamidas de 1,3-tiazolidinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 656029

Country of ref document: ES